Editorial ArticleLife Sciences
Deciphering the mechanisms of dual PD-1 and LAG-3 blockade: A tumor-killing combo or no-go?
University of Pittsburgh researcher, Dr. Lawrence Andrews, shares his latest work unraveling the synergistic role of PD-1 and LAG-3 in cancer immune evasion
